Millipore Launches TMA-Based Mycoplasma-Detection Test for Biomanufacturing
January 28, 2010
Millipore Launches TMA-Based Mycoplasma-Detection Test for Biomanufacturing
Millipore claims that its test, which incorporates transcription-mediated amplification technology developed by Gen-Probe offshoot Roka Bioscience, provides a few advantages over PCR-based Mycoplasma testing.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roka Bioscience Secures $47.5M Financing to Commercialize Food Testing Platform
January 12, 2012 / PCR Insider - Roka Bioscience Raises $20M to Commercialize Food Safety Assays, Instruments
July 28, 2011 / PCR Insider - Canada Accepts Use of Roche's Mycoplasma Detection Test
June 13, 2013 / GenomeWeb Daily News - Hologic Nearly Doubles FY First-Quarter Diagnostics Revenues on Gen-Probe Contributions
February 7, 2013 / PCR Insider - Gen-Probe to Serve as 'Cornerstone' of Hologic's MDx Franchise, Primarily Through STD Test Offerings
May 3, 2012 / PCR Insider